205 related articles for article (PubMed ID: 30622286)
1. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.
Sarungbam J; Mehra R; Tomlins SA; Smith SC; Jayakumaran G; Al-Ahmadie H; Gopalan A; Sirintrapun SJ; Fine SW; Zhang Y; Amin MB; Reuter VE; Chen YB; Tickoo SK
Mod Pathol; 2019 May; 32(5):701-709. PubMed ID: 30622286
[TBL] [Abstract][Full Text] [Related]
2. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
3. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.
Rao Q; Zhang XM; Tu P; Xia QY; Shen Q; Zhou XJ; Shi QL
Int J Clin Exp Pathol; 2013; 6(7):1452-7. PubMed ID: 23826432
[TBL] [Abstract][Full Text] [Related]
5. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
[TBL] [Abstract][Full Text] [Related]
7. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
[TBL] [Abstract][Full Text] [Related]
8. Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.
Tran T; Jones CL; Williamson SR; Eble JN; Grignon DJ; Zhang S; Wang M; Baldridge LA; Wang L; Montironi R; Scarpelli M; Tan PH; Simper NB; Comperat E; Cheng L
Histopathology; 2016 May; 68(6):850-7. PubMed ID: 26310887
[TBL] [Abstract][Full Text] [Related]
9. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
10. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
11. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases.
Pan X; Zhang M; Yao J; Zeng H; Nie L; Gong J; Chen X; Xu M; Zhou Q; Chen N
J Clin Pathol; 2019 Nov; 72(11):748-754. PubMed ID: 31262952
[TBL] [Abstract][Full Text] [Related]
12. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.
Hakimi AA; Tickoo SK; Jacobsen A; Sarungbam J; Sfakianos JP; Sato Y; Morikawa T; Kume H; Fukayama M; Homma Y; Chen YB; Sankin A; Mano R; Coleman JA; Russo P; Ogawa S; Sander C; Hsieh JJ; Reuter VE
Mod Pathol; 2015 Jun; 28(6):845-853. PubMed ID: 25676555
[TBL] [Abstract][Full Text] [Related]
13. Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects.
Zhao M; He XL; Teng XD
Diagn Pathol; 2015 Sep; 10():168. PubMed ID: 26377921
[TBL] [Abstract][Full Text] [Related]
14. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?
Parilla M; Kadri S; Patil SA; Ritterhouse L; Segal J; Henriksen KJ; Antic T
Am J Surg Pathol; 2018 Jul; 42(7):911-917. PubMed ID: 29668487
[TBL] [Abstract][Full Text] [Related]
15. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis.
Al-Hussain TO; Cheng L; Zhang S; Epstein JI
Hum Pathol; 2013 Jul; 44(7):1406-11. PubMed ID: 23427871
[TBL] [Abstract][Full Text] [Related]
16. Gains of chromosomes 7 and 17 in tubulocystic carcinoma of kidney: two cases with fluorescence in situ hybridisation analysis.
Chen N; Nie L; Gong J; Chen X; Xu M; Chen M; Zhou Q
J Clin Pathol; 2014 Nov; 67(11):1006-9. PubMed ID: 25015070
[TBL] [Abstract][Full Text] [Related]
17. A case of tubulocystic carcinoma of the kidney with aggressive features.
Maeda Y; Goto K; Honda Y; Kuroda N; Sentani K; Yasui W; Hayashi T; Teishima J; Matsubara A; Nakamura Y; Toyota N; Iida M; Awai K
Jpn J Radiol; 2016 Apr; 34(4):307-11. PubMed ID: 26830902
[TBL] [Abstract][Full Text] [Related]
18. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.
Cossu-Rocca P; Eble JN; Delahunt B; Zhang S; Martignoni G; Brunelli M; Cheng L
Mod Pathol; 2006 Apr; 19(4):488-93. PubMed ID: 16554730
[TBL] [Abstract][Full Text] [Related]
19. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
20. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]